Iqbal, S., Rankin, C., Lenz, H., Gold, P. J., Ahmad, S. A., El-Khoueiry, A. B., . . . Blanke, C. D. (2011). A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202.
Styl ChicagoIqbal, Syma, Cathryn Rankin, Heinz-Josef Lenz, Philip J. Gold, Syed A. Ahmad, Anthony B. El-Khoueiry, Michael J. Messino, Randall F. Holcombe, a Charles D. Blanke. A Phase II Trial of Gemcitabine and Capecitabine in Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma: Southwest Oncology Group Study S0202. 2011.
Citace podle MLAIqbal, Syma, et al. A Phase II Trial of Gemcitabine and Capecitabine in Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma: Southwest Oncology Group Study S0202. 2011.